Wang Bin, Chen Di, Zhou Hongwei, Shi Huaxin, Xie Qi
J Tradit Chin Med. 2017 Apr;37(2):159-64. doi: 10.1016/s0254-6272(17)30039-0.
To evaluate the influence of clinical pathways in the hospitals using the Traditional Chinese Medicine in treatment of stroke in terms of postoperative complications, length of stay (LOS), costs incurred during hospitalization, compared with standard medical care.
Medline, Embase, China National Knowledge Infrastructure (CNKI) platforms, Wanfang databases and the Cochrane Central Register of Controlled Trials were searched. The search was performed up to August 2014. Each study was assessed independently by two reviewers. The assessment of methodological quality of the included studies was based on the Methodological index for non-randomized studies standard. Meta-analyses were performed using RevMan software, version 5.0.
Six studies met the study inclusion criteria and were included in the Meta-analysis for a total sample of 710 patients. The aggregate overall results showed that shorter length of stay in the clinical pathway group was observed during hospital stay was associated with the use of the clinical pathways. No significant differences were found in other effects.
Regardless the possible limitations, our findings show that clinical pathways can significantly reduce LOS. Although there is no clear evidence that clinical pathways can reduce hospital costs, but the cost of hospitalization path group for each included study were lower than the control group.
与标准医疗护理相比，评估中医院采用中医治疗中风的临床路径对术后并发症、住院时间（LOS）及住院期间费用的影响。
检索了Medline、Embase、中国知网（CNKI）平台、万方数据库及Cochrane对照试验中心注册库。检索截至2014年8月。每项研究由两名评审员独立评估。纳入研究的方法学质量评估基于非随机研究的方法学指标标准。使用RevMan 5.0版软件进行荟萃分析。
六项研究符合研究纳入标准，共710例患者纳入荟萃分析。总体结果显示，临床路径组住院期间住院时间较短与采用临床路径有关。在其他影响方面未发现显著差异。
尽管存在可能的局限性，但我们的研究结果表明临床路径可显著缩短住院时间。虽然没有明确证据表明临床路径可降低医院成本，但各纳入研究中临床路径组的住院费用均低于对照组。
